Research Paper Volume 16, Issue 3 pp 3007—3020
ITGB2 fosters the cancerous characteristics of ovarian cancer cells through its role in mitochondrial glycolysis transformation
Figure 1. Detection of signal pathway expression in clinical samples. (A, B) Immunohistochemical detection of ITGB2-PI3K-AKT-mTOR in clinical samples (ovarian cancer and normal ovarian tissues). (C, D) Data statistics of signal axis Immunohistochemical detection in clinical samples. (E, F) WB detection of ITGB2-PI3K-AKT-mTOR in ovarian cancer cells (SKOV3 and A2780) and normal ovarian cells (IOSE-80).